Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26103
Title: The aetiologies of epilepsy.
Austin Authors: Balestrini, Simona;Arzimanoglou, Alexis;Blümcke, Ingmar;Scheffer, Ingrid E ;Wiebe, Samuel;Zelano, Johan;Walker, Matthew C
Affiliation: UCL Queen Square Institute of Neurology, Member of the ERN EpiCARE, London, UK, Chalfont Centre for Epilepsy, Bucks, UK
Cumming School of Medicine, University of Calgary, Canada
Department of Paediatric Clinical Epileptology and Functional Neurology, University Hospitals of Lyon (HCL), Member of the ERN EpiCARE, Lyon, France, Epilepsy Research Program, Epilepsy Unit, San Juan de Dios Paediatric Hospital, Member of the ERN EpiCARE, Barcelona, Spain
University of Melbourne and Royal Children's Hospital, Florey and Murdoch Children's Research Institutes, Melbourne, Australia
Institute of Neuropathology, University Hospitals Erlangen, Collaborating Partner of the ERN EpiCARE, Erlangen, Germany
Sahlgrenska Academy and University Hospital, Member of the ERN EpiCARE, Gothenburg, Sweden, Wallenberg Center for Molecular and Translational Medicine, Gotenburg, Sweden
UCL Queen Square Institute of Neurology, Member of the ERN EpiCARE, London, UK
Austin Health
Issue Date: 1-Feb-2021
Date: 2021-02-01
Publication information: Epileptic Disorders 2021; 23(1): 1-16
Abstract: The identification of the aetiology of a patient's epilepsy is instrumental in the diagnosis, prognostic counselling and management of the epilepsies. Indeed, the aetiology can be important for determining the recurrence risk of single seizures and so for making a diagnosis of epilepsy. Here, we divide the aetiologies into six categories: structural, genetic, infectious, metabolic, immune (all of which are part of the International League Against Epilepsy [ILAE] classification system) and neurodegenerative (which we have considered separately because of its growing importance in epilepsy). These are not mutually exclusive categories and many aetiologies fall into more than one category. Indeed, genetic factors probably play a role, to varying degrees, in the risk of seizures in all people with epilepsy. In each of the categories, we discuss what we regard as the most important aetiologies; importance being determined not only by prevalence but also by clinical significance. The introduction contains information suitable for level 1 competency (entry level), whilst the subsequent sections contain information aimed at level 2 competency (proficiency level) as part of the new ILAE competency-based curriculum. As we move towards precision medicine and targeted therapies, so aetiologies will play an even greater role in the management of epilepsy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26103
DOI: 10.1684/epd.2021.1255
Journal: Epileptic Disorders
PubMed URL: 33720020
Type: Journal Article
Subjects: genetic
immune
infectious
metabolic
neurodegenerative
structural
Appears in Collections:Journal articles

Show full item record

Page view(s)

42
checked on Apr 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.